BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Catalyst Brief//FDA catalyst calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Catalyst Brief — FDA catalyst calendar
REFRESH-INTERVAL;VALUE=DURATION:PT6H
X-PUBLISHED-TTL:PT6H
BEGIN:VEVENT
UID:event-75@catalystbrief.girapphe.com
DTSTAMP:20261117T061555Z
LAST-MODIFIED:20261117T061555Z
DTSTART;VALUE=DATE:20270301
DTEND;VALUE=DATE:20270302
SUMMARY:Readout: Anhui Zhifei Longcom Biologic Pharmacy Co.\, Ltd. — quad
 rivalent recombinant norovirus vaccine (Pichia pastoris) [Mar 2027]
DESCRIPTION:Phase 3 primary completion: Clinical Trial of Protective Effica
 cy of Quadrivalent Recombinant Norovirus Vaccine (Pichia Pastoris).\nSourc
 e: https://clinicaltrials.gov/study/NCT06524947\nhttps://catalystbrief.gir
 apphe.com/e/75?lang=en\nNot investment advice. Dates may change.
URL:https://catalystbrief.girapphe.com/e/75?lang=en
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
